These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 207742)

  • 41. Update on the use of dapsone in dermatology.
    Ghaoui N; Hanna E; Abbas O; Kibbi AG; Kurban M
    Int J Dermatol; 2020 Jul; 59(7):787-795. PubMed ID: 31909480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effect of Pseudomonas aeruginosa on the phagocytic and killing activity of rabbit polymorphonuclear leukocytes: mechanisms of action of a polymorphonuclear leukocyte inhibitor.
    Nonoyama S; Kojo H; Mine Y; Nishida M; Goto S; Kuwahara S
    Infect Immun; 1979 May; 24(2):399-403. PubMed ID: 110701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible dapsone-induced peripheral neuropathy in dermatitis herpetiformis.
    du Vivier A; Fowler T
    Proc R Soc Med; 1974 Jun; 67(6 Pt 1):439-40. PubMed ID: 4369028
    [No Abstract]   [Full Text] [Related]  

  • 44. Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study.
    Wozel G; Blasum C; Winter C; Gerlach B
    Inflamm Res; 1997 Oct; 46(10):420-2. PubMed ID: 9372316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dapsone-induced peripheral neuropathy.
    Epstein FW; Bohm M
    Arch Dermatol; 1976 Dec; 112(12):1761-2. PubMed ID: 188385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of the protective effects of the antioxidants ascorbate, cysteine, and dapsone on the phagocyte-mediated oxidative inactivation of human alpha-1-protease inhibitor in vitro.
    Theron A; Anderson R
    Am Rev Respir Dis; 1985 Nov; 132(5):1049-54. PubMed ID: 2998243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of phagocytic processes and antibody-dependent cellular cytotoxicity of human neutrophils by cefmetazole.
    Rodriguez AB; Barriga C; de la Fuente M
    Microbiol Immunol; 1991; 35(7):545-56. PubMed ID: 1784256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring.
    Meylan PR; Markert M; Bille J; Glauser MP
    Infect Immun; 1989 Jul; 57(7):2196-202. PubMed ID: 2543635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the inhibitory effects of analogues of dapsone on neutrophil function in-vitro.
    Coleman MD; Smith JK; Perris AD; Buck NS; Seydel JK
    J Pharm Pharmacol; 1997 Jan; 49(1):53-7. PubMed ID: 9120771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloperoxidase--H2O2--halide system: cytotoxic effect on human blood leukocytes.
    Clark RA; Klebanoff SJ
    Blood; 1977 Jul; 50(1):65-70. PubMed ID: 194641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ascorbate-mediated stimulation of neutrophil motility and lymphocyte transformation by inhibition of the peroxidase/H2O2/halide system in vitro and in vivo.
    Anderson R
    Am J Clin Nutr; 1981 Sep; 34(9):1906-11. PubMed ID: 7282616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diaminodiphenyl sulfone in dermatitis herpetiformis.
    MARCH C; SAWICKY HH
    Arch Dermatol; 1962 Jun; 85():751-2. PubMed ID: 14469594
    [No Abstract]   [Full Text] [Related]  

  • 53. Impairment of some granulocyte functions in Sweet's syndrome.
    von den Driesch P; Simon M; Schlegel Gomez R; Hornstein OP
    Acta Derm Venereol; 1992; 72(2):109-11. PubMed ID: 1350393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ultrastructural changes in the skin in dermatitis herpetiformis after withdrawal of dapsone.
    Riches DJ; Martin BG; Seah PP; Fry L
    Br J Dermatol; 1976 Jan; 94(1):31-7. PubMed ID: 1252338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis.
    Katz SI
    Arch Dermatol; 1982 Oct; 118(10):805-12. PubMed ID: 6753759
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of Eglin C on the function of human neutrophils in vitro.
    Suter S; Chevallier I
    Biol Chem Hoppe Seyler; 1988 Jul; 369(7):573-8. PubMed ID: 2852014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.
    Paton JC; Ferrante A
    Infect Immun; 1983 Sep; 41(3):1212-6. PubMed ID: 6885160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. Role in depressed bactericidal activity.
    Abramson JS; Lewis JC; Lyles DS; Heller KA; Mills EL; Bass DA
    J Clin Invest; 1982 Jun; 69(6):1393-7. PubMed ID: 7085879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of bioflavonoids on phagocytosis, intracellular bactericidal activity and chemotaxis of human polymorphonuclear cells.
    Pruzanski W; Nitzan DW; Saito S
    Asian Pac J Allergy Immunol; 1983 Dec; 1(2):97-103. PubMed ID: 6681014
    [No Abstract]   [Full Text] [Related]  

  • 60. Adriamycin impairs phagocytic function and induces morphologic alterations in human neutrophils.
    Vaudaux P; Kiefer B; Forni M; Joris I; Majno G; Waldvogel FA
    Cancer; 1984 Aug; 54(3):400-10. PubMed ID: 6203635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.